Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
Clinical trial NCT03651206 · RECRUITING
Trial details
- NCT number
- NCT03651206
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2027-06-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.